Sana Biotechnology (SANA) Retained Earnings (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Retained Earnings data on file, last reported at $2.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings changed N/A year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (changed N/A YoY), and the FY2025 full-year result was $2.0 billion, up 14355935.71% from the prior year.
• Retained Earnings was little changed at $2.0 billion in Q1 2026, from $2.0 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $2.0 billion in Q1 2026 to a low of -$1.8 billion in Q3 2025.
• A 5-year average of $400.2 million and a median of $773.4 million in 2022 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings slumped 48923.08% in 2022 and soared 14355935.71% in 2025, its largest moves.
• Tracing SANA's Retained Earnings over 5 years: stood at $1.6 billion in 2022, then rose by 4.31% to $1.6 billion in 2023, then plunged by 100.0% to $14000.0 in 2024, then soared by 14355935.71% to $2.0 billion in 2025, then advanced by 0.28% to $2.0 billion in 2026.
• Business Quant data shows SANA's Retained Earnings at $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and -$1.8 billion in Q3 2025.